NCT00317785View on ClinicalTrials.gov

Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

November 30, 2007

Conditions

LeukemiaLymphomaMyelodysplastic Syndromes

Interventions

DRUG

cyclophosphamide

DRUG

cyclosporine

DRUG

methotrexate

DRUG

mycophenolate mofetil

DRUG

sirolimus

DRUG

tacrolimus

OTHER

pharmacological study

PROCEDURE

allogeneic bone marrow transplantation

PROCEDURE

allogeneic hematopoietic stem cell transplantation

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

total-body irradiation

Trial Locations (2)

98109-1023

Seattle Cancer Care Alliance, Seattle

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00317785 - Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases | Biotech Hunter | Biotech Hunter